These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 32276211)

  • 1. Anti-microbial and anti-biofilm activities of combined chelerythrine-sanguinarine and mode of action against Candida albicans and Cryptococcus neoformans in vitro.
    Qian W; Yang M; Li X; Sun Z; Li Y; Wang X; Wang T
    Colloids Surf B Biointerfaces; 2020 Jul; 191():111003. PubMed ID: 32276211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antifungal and antibiofilm activities of halogenated quinoline analogues against Candida albicans and Cryptococcus neoformans.
    Zuo R; Garrison AT; Basak A; Zhang P; Huigens RW; Ding Y
    Int J Antimicrob Agents; 2016 Aug; 48(2):208-11. PubMed ID: 27256584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal and Antibiofilm Efficacy of Paeonol Treatment Against Biofilms Comprising
    Qian W; Li X; Liu Q; Lu J; Wang T; Zhang Q
    Front Cell Infect Microbiol; 2022; 12():884793. PubMed ID: 35669114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of Sanguinarine against Candida albicans Biofilms.
    Zhong H; Hu DD; Hu GH; Su J; Bi S; Zhang ZE; Wang Z; Zhang RL; Xu Z; Jiang YY; Wang Y
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223387
    [No Abstract]   [Full Text] [Related]  

  • 5. Chelerythrine reverses the drug resistance of resistant
    Gong Y; Yin S; Sun S; Li M
    Future Microbiol; 2022 Nov; 17():1325-1333. PubMed ID: 36111728
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Gong Y; Li S; Wang W; Li Y; Ma W; Sun S
    Future Microbiol; 2019 Dec; 14():1545-1557. PubMed ID: 31992072
    [No Abstract]   [Full Text] [Related]  

  • 7. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
    Jafri H; Ahmad I
    J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Antifungal Efficacy of Three New Cyclic Lipopeptides of the Class Bacillomycin from Bacillus subtilis RLID 12.1.
    Ramachandran R; Shrivastava M; Narayanan NN; Thakur RL; Chakrabarti A; Roy U
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens.
    Mamouei Z; Alqarihi A; Singh S; Xu S; Mansour MK; Ibrahim AS; Uppuluri P
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans.
    Ghannoum MA; Fu Y; Ibrahim AS; Mortara LA; Shafiq MC; Edwards JE; Criddle RS
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2459-65. PubMed ID: 8585726
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Tetz G; Collins M; Vikina D; Tetz V
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antifungal activity of eugenol and vanillin against Candida albicans and Cryptococcus neoformans.
    Boonchird C; Flegel TW
    Can J Microbiol; 1982 Nov; 28(11):1235-41. PubMed ID: 6758923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal activity of promethazine and chlorpromazine against planktonic cells and biofilms of Cryptococcus neoformans/Cryptococcus gattii complex species.
    Brilhante RSN; Gotay WJP; Pereira VS; de Oliveira JS; Pereira-Neto WA; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
    Med Mycol; 2020 Oct; 58(7):906-912. PubMed ID: 32016364
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Fu Y; Liu W; Liu M; Zhang J; Yang M; Wang T; Qian W
    Biofouling; 2021 Mar; 37(3):341-351. PubMed ID: 33947279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal activity of peptide MSI-1 against Cryptococcus neoformans infection in vitro and in murine cryptococcal meningoencephalitis.
    Ma L; Wei S; Ye X; Xu P; Chen H; Liu Z; Zhou C
    Peptides; 2020 Aug; 130():170334. PubMed ID: 32504765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-biofilm activity of the metabolites of Streptomyces chrestomyceticus strain ADP4 against Candida albicans.
    Srivastava V; Dubey AK
    J Biosci Bioeng; 2016 Oct; 122(4):434-40. PubMed ID: 27117484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Antifungal Action Mode of
    Staniszewska M; Kuryk Ł; Gryciuk A; Kawalec J; Rogalska M; Baran J; Kowalkowska A
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
    Martinez LR; Casadevall A
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1021-33. PubMed ID: 16495265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bigger Data Approach to Analysis of Essential Oils and Their Antifungal Activity against
    Powers CN; Satyal P; Mayo JA; McFeeters H; McFeeters RL
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexplored antifungal activity of linear battacin lipopeptides against planktonic and mature biofilms of C. albicans.
    De Zoysa GH; Glossop HD; Sarojini V
    Eur J Med Chem; 2018 Feb; 146():344-353. PubMed ID: 29407961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.